Efficacy of Quetiapine Compared to Risperidone on Negative Symptoms and Cognition With Regard to Underlying Neurobiological Mechanisms and Brain Activation.

Trial Profile

Efficacy of Quetiapine Compared to Risperidone on Negative Symptoms and Cognition With Regard to Underlying Neurobiological Mechanisms and Brain Activation.

Completed
Phase of Trial: Phase III

Latest Information Update: 16 Jun 2009

At a glance

  • Drugs Quetiapine; Risperidone
  • Indications Schizophrenia
  • Focus Therapeutic Use
  • Sponsors AstraZeneca
  • Most Recent Events

    • 16 Jun 2009 Trial phase changed from IV to III as reported by ClinicalTrials.gov.
    • 17 Dec 2007 Status changed from in progress to completed as reported by ClinicalTrials.gov.
    • 10 Oct 2006 Status change
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top